At this time we are not accepting any new patients to the BHRT program. October 2019
Androgen replacement therapy is a hormone treatment often prescribed to counter the effects of male hypogonadism, which is the diminished functional activity of the gonads. Hypogonadism can be present at birth, or it can also be acquired through means such as mumps, traumatic brain injury, or prolonged use of opiod class drugs. Androgen replacement therapy can also be prescribed to lessen the effects or delay the onset of normal male aging. Additionally, androgen replacement therapy can be used for men who have lost their testicular function from disease, cancer, or other causes. Learn more about HRT for men here.
Read about Annie’s experience with bio-identical hormone replacement therapy in our Lifestyle Therapies Center and other real patient stories in Real Patient Stories. As a young woman, Annie was facing hormonal issues which negatively impacted her life and marriage. As a last resort, Annie tried BHRT, which changed her life. Find out why her husband was even more excited than Annie in telling her story. He got back the woman he married, and we couldn’t be happier for them.
FVPS performs hormone/androgen replacement therapy for men and women by prescribing natural bio-identical hormones in the form of pellets. While bio-identical hormones have been approved and available for use in the US since the 1930s, the use of bio-identical hormones has been slow to increase despite general agreement in the scientific literature that bio-identical hormone replacement is better than using traditional HRT with non-human hormones.
Any type of hormone replacement therapy can increase the risk of breast cancer among average weight post menopausal women, so patients should make their primary care providers aware if they elect to receive bio-identical hormones. For some people, the slightly increased risk of breast cancer is offset by the greater quality of life while on BHRT. FVPS requires all patients to have a regular primary care doctor, and all female patients to be current on mammograms, pap smears, and bone density screening tests.
A 2019 analysis in The Lancet calculated these risks of developing breast cancer by age 69:
The Lancet made these points:
The findings show only an association between HRT and breast cancer; they don’t prove a causal relationship.